GlassScriptPhysician profile
Diana V Dang
NPI 1073870986
$16,747.26
in general payments reported to CMS, 2019-2025
44 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $337 · 2021: $589 · 2022: $8,259 · 2023: $2,796 · 2024: $3,249 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,602 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,375 · Education: $1,242 · Travel and Lodging: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,601.58 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,375.00 |
| Education | $1,241.94 |
| Travel and Lodging | $862.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,065.68 | 2022-2024 | Da Vinci Surgical System |
| Organon LLC | $3,013.47 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $844.75 | 2019-2024 | Ubrelvy, Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $735.76 | 2022-2025 | |
| Astellas Pharma US INC | $591.26 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $432.76 | 2019-2025 | Slynd |
| Pfizer INC. | $357.96 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $344.44 | 2023-2025 | Myfembree, Gemtesa |
| Amgen INC. | $209.69 | 2019-2024 | Evenity, Prolia |
| Evofem Biosciences, INC. | $197.56 | 2021-2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $176.11 | 2020-2025 | |
| Hologic Sales and Service, LLC | $175.38 | 2019-2025 | Aptima |
| Therapeuticsmd, INC. | $173.14 | 2020-2021 | |
| Davol INC. | $110.40 | 2024 | Arista Ah Flexitip |
| Ucb, INC. | $108.30 | 2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.